ACTRN12618001633279已完成未知
Evaluation of the Efficacy of Sugammadex Based on Ideal Body Weight of Obstetric Patients with Different Groups of Body Mass Indexes for Reversal of Moderate Rocuronium-Induced Neuromuscular Blockade
Basak ALTIPARMAK0 个研究点目标入组 90 人开始时间: 2018年10月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Female
入选标准
- •The patients over 18 years old with ASA status II and scheduled for an elective caesarean section under general anesthesia
排除标准
- •presence of pulmonary diseases (asthma, chronic obstructive pulmonary disease etc), known allergy to study drugs, use of medications that can affect neuromuscular blockade such as magnesium sulphate, anticonvulsive drugs, macrolids and aminoglycosides, decline participation to the study
研究者
相似试验
尚未招募
4 期
Comparative study to find the effective dose of sugammadex to reverse the eefectbof muscle relaxants in patients undergoing General Surgery receiving muscle relaxants in general anesthesiaCTRI/2024/06/068590Vijayanagar Institute of Medical Sciences
尚未招募
Unknown
To Evaluate the Efficacy of Sugammadex in Reversing the effect of a Muscle Relaxant in Patients Undergoing Major Upper Abdominal Surgery: An Observational StudyCTRI/2023/07/055172Dr. Ram Manohar Lohia Institute of Medical Sciences
进行中（未招募）
不适用
Comparison of effects of sugammadex administration timing on the success rate of neuromuscular function monitoring before endotracheal tube extubation and recovery profile in patients undergoing general anesthesiaKCT0007899Konyang University Hospital80
尚未招募
Unknown
Comparison of the effects of sugamadex dosage on the reversal of neuromuscular blockadeand recovery profile in adult patients under general anesthesiaKCT0008773Konyang University Hospital52
进行中（未招募）
1 期
Evaluation of the efficacy and safety of sugammadex (Bridion) in children with renal failure. - sugammadex in children with renal failureSugammadex is a selective relaxant binding agent, which is administered in case of a rocuronium-induced neuromuscular block, during general anaesthesia. The aim of the trial is to investigate the use, efficacy and safety of sugammadex in children (2-17 years) with moderate to severe renal failure (creatinine clearance < 30 ml/min), compared to children with normal renal function.MedDRA version: 9.1Level: HLTClassification code 10038443Term: Renal failure and impairmentMedDRA version: 9.1Level: LLTClassification code 10009119Term: Chronic renal failureMedDRA version: 9.1Level: LLTClassification code 10014647Term: End stage renal failureEUCTR2008-008246-20-NLRadboud University Nijmegen Medical Center, Department of Anaesthesiology, Pain and Palliative Medic20